MHRA issues recall alert for Abstral 200 microgram tablets

The Medicines and Health products Regulatory Agency (MHRA) has issued a class two medicines recall for Abstral 200 microgram sublingual tablets.

Kyowa Kirin Limited is recalling the tablets batch as a precautionary measure, due to the reports of double tablets in a single blister pocket.

This was identified during reference sample inspection and there is a potential low risk of accidental double dosage.

The pharmacists have been adviced to stop supplying the batch immediately and quarantine all remaining stock and return it to their supplier.